STEPAN CO
Business
STEPAN CO produces specialty and intermediate chemicals sold to other manufacturers for use in a variety of end products. It offers surfactants, polymers (including polyurethane polyols, polyester resins and phthalic anhydride) and specialty products used in cleaning and personal care, industrial and construction, agricultural, food, flavoring, nutritional supplement and pharmaceutical applications. The company reports three business segments—Surfactants, Polymers and Specialty Products—providing formulation, technical support and manufacturing services. STEPAN sells through business-to-business channels to a wide range of manufacturers across regional and global markets and does not sell directly to retail customers.
Summary from filing dated 2025-02-27
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Net Sales (Note 1) | 2,332 | 2,180 | 2,326 | 2,773 | 2,346 | |
| Cost of Sales | 2,062 | 1,908 | 2,048 | 2,346 | 1,950 | |
| Gross Profit | 270 | 272 | 278 | 427 | 396 | |
| Selling (Note 1) | 49 | 46 | 48 | 59 | 59 | |
| Administrative (Note 1) | 91 | 98 | 93 | 102 | 93 | |
| Research, development and technical services (Note 1) | 59 | 56 | 59 | 67 | 63 | |
| Deferred compensation expense (Note 12) | 2 | 2 | 4 | −9 | 7 | |
| Total Operating expenses | 201 | 202 | 205 | 218 | 222 | |
| Goodwill and other intangibles impairment (Note 4) | 6 | — | 2 | 978,000 | — | |
| Business restructuring and assets impairment (Note 22) | — | — | 12 | 308,000 | 3 | |
| Gain on sales of assets (Note 20) | 16 | — | — | — | — | |
| Operating Income | 79 | 70 | 59 | 207 | 171 | |
| Interest, net (Note 6) | −22 | −14 | −12 | −10 | −6 | |
| Other, net (Note 8) | 3 | 4 | 2 | −9 | 8 | |
| Nonoperating Income (Expense), Total | −19 | −10 | −10 | −19 | 2 | |
| Income Before Provision for Income Taxes | 60 | 60 | 48 | 189 | 173 | |
| Provision for Income Taxes (Note 9) | 13 | 10 | 8 | 42 | 35 | |
| Net Income | 47 | 50 | 40 | 147 | 138 | |
| Basic (per share) | 2.05 | 2.21 | 1.77 | 6.46 | 6.01 | |
| Diluted (per share) | 2.05 | 2.2 | 1.75 | 6.38 | 5.92 | |
| Basic (shares) | 23 | 23 | 23 | 23 | 23 | |
| Diluted (shares) | 23 | 23 | 23 | 23 | 23 |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 133 | 100 | 130 | 174 | 159 | |
| Receivables, less allowances of $10,533 in 2025 and $10,827 in 2024 | 388 | 388 | 422 | 437 | 420 | |
| Inventories (Note 5) | 299 | 289 | 266 | 403 | 306 | |
| Other current assets | 39 | 34 | 34 | 32 | 29 | |
| Total current assets | 859 | 810 | 852 | 1,045 | 913 | |
| Land | 58 | 54 | 53 | 51 | 51 | |
| Buildings and improvements | 455 | 399 | 335 | 293 | 261 | |
| Machinery and equipment | 2,161 | 1,917 | 1,797 | 1,640 | 1,542 | |
| Construction in progress | 113 | 275 | 400 | 386 | 238 | |
| Property, Plant and Equipment, Gross | 2,787 | 2,646 | 2,585 | 2,371 | 2,091 | |
| Less: Accumulated depreciation | −1,567 | −1,447 | −1,378 | −1,297 | −1,240 | |
| Property, plant and equipment, net | 1,220 | 1,198 | 1,207 | 1,073 | 851 | |
| Goodwill, net (Note 4) | 93 | 91 | 97 | 96 | 97 | |
| Other intangible assets, net (Note 4) | 40 | 43 | 53 | 58 | 61 | |
| Long-term investments (Note 2) | 21 | 26 | 27 | 23 | 34 | |
| Operating lease assets (Note 7) | 62 | 71 | 71 | 63 | 70 | |
| Other non-current assets | 63 | 65 | 57 | 75 | 40 | |
| Total Assets | 2,358 | 2,305 | 2,363 | 2,433 | 2,066 | |
| Current maturities of debt (Note 6) | 286 | 293 | 253 | 132 | 41 | |
| Accounts payable | 262 | 259 | 233 | 376 | 323 | |
| Accrued liabilities (Note 14) | 119 | 117 | 122 | 163 | 136 | |
| Total current liabilities | 666 | 669 | 608 | 671 | 500 | |
| Deferred income taxes (Note 9) | 11 | 10 | 10 | 10 | 12 | |
| Long-term debt, less current maturities (Note 6) | 341 | 333 | 401 | 455 | 323 | |
| Non-current operating lease liability (Note 7) | 49 | 57 | 58 | 51 | 57 | |
| Other non-current liabilities (Note 15) | 45 | 66 | 69 | 81 | 99 | |
| Commitments and Contingencies (Note 16) | — | — | — | — | — | |
| Common stock, $1 par value; 60,000,000 authorized shares; 27,301,177 issued shares in 2025 and 27,156,436 issued shares in 2024 | 27 | 27 | 27 | 27 | 27 | |
| Additional paid-in capital | 260 | 254 | 247 | 237 | 221 | |
| Accumulated other comprehensive loss (Note 19) | −139 | −197 | −131 | −168 | −153 | |
| Retained earnings | 1,286 | 1,274 | 1,257 | 1,250 | 1,134 | |
| Less: Common treasury stock, at cost, 4,676,739 shares in 2025 and 4,655,798 shares in 2024 | −190 | −188 | −184 | −181 | −154 | |
| Total Stepan Company stockholders equity | 1,244 | 1,170 | 1,216 | 1,166 | 1,074 | |
| Total Liabilities and Equity | 2,358 | 2,305 | 2,363 | 2,433 | 2,066 |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Depreciation and amortization | 126 | 112 | 105 | 95 | 91 | |
| Realized and unrealized (gains) on long-term investments | −2 | −3 | −4 | 8 | −2 | |
| Stock-based compensation | 6 | 5 | 6 | 14 | 12 | |
| Deferred income taxes | −1 | −10 | 18 | −27 | −34 | |
| Goodwill and other intangibles impairment (Note 4) | 6 | — | 2 | 978,000 | — | |
| Other non-cash items | −14 | 3 | 5 | 2 | 2 | |
| Receivables, net | 24 | 9 | 32 | −26 | −104 | |
| Inventories | 500,000 | −37 | 145 | −99 | −79 | |
| Other current assets | −7 | −1,000 | −5 | −4 | −1 | |
| Accounts payable and accrued liabilities | −33 | 34 | −159 | 54 | 44 | |
| Pension liabilities | −3 | −131,000 | −1 | −2 | −2 | |
| Environmental and legal liabilities | −680,000 | −695,000 | −12 | 10 | 450,000 | |
| Deferred revenues | −3 | −2 | −2 | −962,000 | 277,000 | |
| Net Cash Provided By Operating Activities | 148 | 162 | 175 | 161 | 72 | |
| Expenditures for property, plant and equipment | −123 | −123 | −260 | −302 | −194 | |
| Proceeds from sales of assets (Note 20) | 27 | 0 | 0 | — | — | |
| Other, net | 7 | 6 | 2 | 3 | 1 | |
| Net Cash Used In Investing Activities | −89 | −117 | −259 | −308 | −377 | |
| Revolving debt and bank overdrafts, net (Note 6) | −11 | 20 | 105 | — | — | |
| Other debt borrowings (Note 6) | 75 | — | — | 75 | 200 | |
| Other debt repayments (Note 6) | −63 | −49 | −38 | — | — | |
| Dividends paid | −35 | −34 | −33 | −31 | −28 | |
| Stock option exercises | 104,000 | 1 | 3 | 782,000 | 1 | |
| Other, net | −2 | −3 | −4 | −3 | −4 | |
| Net Cash Provided By (Used In) Financing Activities | −35 | −65 | 33 | 166 | 117 | |
| Effect of Exchange Rate Changes on Cash | 10 | −11 | 7 | −4 | −3 | |
| Net Increase (Decrease) in Cash and Cash Equivalents | 33 | −30 | −44 | 15 | −191 | |
| Cash payments of income taxes, net of refunds (Note 9) | 8 | −12 | 30 | 42 | 93 | |
| Cash payments of interest | 29 | 30 | 28 | 17 | 10 |